The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; MSD; Pfizer
Speakers' Bureau - DAKO; Roche; Thermo Fisher Scientific
 
Research Funding - Novartis
Molecular alterations and late recurrence in postmenopausal women with hormone receptor-positive node-positive breast cancer (BC): Results from the “SOLE” trial.
 
Elena Guerini Rocco
Consulting or Advisory Role - Life Technologies; Thermo Fisher Scientific
Travel, Accommodations, Expenses - Life Technologies; Thermofisher Scientific Biomarkers
 
Kathryn P. Gray
Stock and Other Ownership Interests - MDGN
 
Elisabetta Munzone
Consulting or Advisory Role - Pierre Fabre
 
Caterina Fumagalli
Consulting or Advisory Role - Roche
 
Marta Rita Reforgiato
No Relationships to Disclose
 
Isabella Leone
No Relationships to Disclose
 
Rosita Kammler
No Relationships to Disclose
 
Giuseppe Viale
Honoraria - MSD Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dako; Roche/Genentech
Research Funding - Roche/Genentech; Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Celgene; Roche
 
Patrick Neven
No Relationships to Disclose
 
Erika Hitre
No Relationships to Disclose
 
Guy Heinrich Maria Jerusalem
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Lilly; Novartis; Pfizer; Puma Biotechnology; Roche
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
 
Edda Simoncini
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Andrea Gombos
No Relationships to Disclose
 
Ines Deleu
No Relationships to Disclose
 
Angelo Di Leo
Honoraria - AstraZeneca; Bayer; Celgene; Eisai; Genomic Health; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Daiichi Sankyo; Ipsen; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche
Research Funding - AstraZeneca; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Celgene; Daiichi Sankyo; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche
 
Aron Goldhirsch
No Relationships to Disclose
 
Massimo Barberis
No Relationships to Disclose
 
Meredith M. Regan
Consulting or Advisory Role - Ipsen (Inst); Merck
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ferring (Inst); Ipsen (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); OncoGenex (Inst); Pfizer (Inst); Pierre Fabre (Inst); Veridex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Marco Colleoni
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Celldex; OBI Pharma; Pfizer; Pierre Fabre; Puma Biotechnology